SELPLG and chronic obstructive pulmonary disease: In addition to its real-world design, our study uniquely contributes by directly comparing individuals with COPD, IHD, and healthy controls within the same experimental framework, and by exploring potential protective mechanisms, including the use of inhaled or cardiac medications and the modulation of NO2-cLA, a cardioprotective lipid mediator.